June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Dynamic Intraductal Meibomian Probing (DIMP): A Novel Approach to the Treatment of Meibomian Gland Dysfunction
Author Affiliations & Notes
  • Zeba Almas Syed
    Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Francis Sutula
    Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Footnotes
    Commercial Relationships Zeba Syed, None; Francis Sutula, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4761. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Zeba Almas Syed, Francis Sutula; Dynamic Intraductal Meibomian Probing (DIMP): A Novel Approach to the Treatment of Meibomian Gland Dysfunction. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4761.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Meibomian gland dysfunction (MGD) is among the most common disorders treated by ophthalmologists. Warm compresses and lid hygiene usually do not provide lasting symptom relief. Meibomian gland probing has been shown to be effective in severe posterior blepharitis. Here we describe a modified technique, Dynamic Intraductal Meibomian Probing (DIMP), which has several advantages over traditional probing including greater magnification, stabilization of the patient’s head, facilitated probing against resistance, and easier identification of orifices

 
Methods
 

A retrospective chart review was performed on patients undergoing DIMP by one physician between January 2013 and July 2014. Inclusion criteria were patients with symptomatic MGD (dryness, tearing, foreign body sensation, and/or irritation) and clinical signs of MGD (eyelid erythema, thickening, irregularity, and/or telangiectasias) who did not respond to conservative therapies including warm compresses, lid hygiene, and topical anti-inflammatory medications. We reviewed the electronic medical records for the presence of symptoms after DIMP treatment.<br /> <br /> During DIMP, the patient is seated supine on a surgical chair and an operating microscope is positioned over the target lid. Von Graefe fixation forceps are used to grasp the lid and apply upward traction, and a 2 mm probe is inserted to dilate each meibomian gland orifice sequentially along the lid margin. The 4 mm probe is then substituted to allow for deeper probing. After DIMP, meibum spontaneously expresses through glands along the lid margin.

 
Results
 

Thirty-six eyes of 22 patients underwent DIMP treatment. The average age of patients was 59 years. Eleven patients were male and 11 were female. The majority (82%) of procedures were performed on a lower lid. Follow-up ranged from 1 to 16 weeks, with a mean of 3.5 months (± 3.1 months). Most (92% ± 4.6%) patients reported symptomatic improvement during follow-up. No major complications were noted. Rarely, small areas of bleeding were appreciated at ductal orifices. This always stopped spontaneously without need to apply pressure.

 
Conclusions
 

DIMP is an effective and safe technique for symptomatic MGD that is resistant to traditional therapies. The development of tools to quantify the severity of MGD would allow for more objective outcome measurements.  

 
Dynamic Intraductal Meibomian Probing (DIMP)
 
Dynamic Intraductal Meibomian Probing (DIMP)
 
 
Release of Meibum After DIMP
 
Release of Meibum After DIMP

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×